Incorporating some potential obstacles arising from recent Chinese developments
15/09/23 -"Despite Philips gaining confidence, thanks to promising testing results for respiratory devices, improving operations and a big new investor coming on board, our target price resets lower due to ..."
Pages
69
Language
English
Published on
15/09/23
You may also be interested by these reports :
04/11/26
Following preliminary figures reported last month, Demant has released its Q3 report. As announced in Q3, hearing aids benefited from strong initial ...
04/11/26
Fresenius delivered a solid Q3, with revenue broadly in line and adjusted EBIT 3.2% ahead of consensus. Biopharma kept compounding and has already ...
03/11/26
Philips’ Q3 profitability exceeded expectations. Most segments contributed to topline growth, while the largest contributor, Diagnosis treatment, ...
03/11/26
FMC’s Q3 26 beat consensus, but the underlying picture is weak: organic revenue was flat, adjusted EBIT fell 6% and US SMTG worsened to -1.1%. FY26 ...